	Management Team

	Expansion Media

	Advisory Team

	Grants and Development






Site By studi[o]z

Management Team

David Anthony - Managing Partner

David Anthony is an experienced entrepreneur, venture capitalist, and educator. Since founding 21Ventures in 2004, the firm has provided seed, growth, and bridge capital to over 40 technology ventures across the globe focusing mainly in the cleantech arena. David Anthony sits on the board of a number of 21V portfolio companies including (partial list) Advanced Telemetry; BioPetroClean, ETV Motors, and Variable Wind Solutions. David also serves on the board of directors of publicly traded companies Axion Power International, Inc. (OTC: AXPW); Clean Power Technologies Inc. (OTC: CPWE) Solar EnerTech Corp. (OTC: ENSL), Energy Focus, Inc.(NASDAQ: EFOI) and ThermoEnergy Corporation (OTC: TMEN).

David Anthony is an Adjunct Professor at the New York Academy of Sciences (NYAS). The Academy, based in Manhattan brings together scientists of different disciplines from around the world to advance the understanding of science, technology, and medicine, and to stimulate new ways to think about how their research is applied in society and the world. The Academy is widely recognized as one of the world's foremost organizers of scientific conferences and symposia. David's students at the Academy hail from such prestigious institutions as Columbia, NYU, Princeton, Yale, Rockefeller University, Sloan Kettering, and the Albert Einstein College of Medicine.

Previously, Mr. Anthony collaborated with Dartmouth College professor Dr. John K. Shank and consulted for Fortune 500 clients on capital investments, mergers and acquisitions, and entrepreneurship. In addition David is an adjunct professor at the NYU Stern School of business where he began teaching technology entrepreneurship in the Fall of 2009.

David received his MBA from The Tuck School of Business at Dartmouth College in 1989 and a BA in economics from George Washington University in 1982. He is an entrepreneurship mentor at the Land Center for Entrepreneurship at Columbia University Graduate School of Business. In 2002, David was awarded the Distinguished Mentor of the Year Award from Columbia University.

David blogs at www.davidanthonyvc.com

Dileep Agnihotri - Principal

Dr. Dileep Agnihotri, a principal at 21 Ventures, is leading two companies (Graphene Energy and Advanced Hydro) as their acting CEO. Before joining 21 Ventures, Dileep spent 8 years with another technology start-up, “Jordan Valley Semiconductors”, a private company, which became #3 in the overall thin-film metrology market and #1 in the x-ray based, in-line thin film, metrology for semiconductor manufacturing. Dileep ramped up a technical team for worldwide applications and actively contributed to the technology development. He worked in capacity of director and a world-wide manager in the company. He managed a team of talented people for technology development, applications development and strategic, technical and product marketing. Prior to Jordan Valley, Dileep worked for another start-up “Amia Laboratories” which was acquired by a larger private company, “Rigaku”, a world leader in the field of analytical x-ray instruments. Dileep has over 10 years of experience in managing cross disciplinary technical teams, technology development and start-ups. He also played a pioneering role in the introduction of fast x-ray metrologies to semiconductor manufacturing. He also spent 8 years in the field of Nuclear Chemistry, which involved neutron and charge particle detection technologies and research on fundamental nuclear matter interactions.

Dileep holds a PhD in Nuclear Chemistry/Physics and an MS degree in Physical Chemistry from the University of Rochester, NY. He also has an MS degree in Physics from Agra University. Dileep has published over 30 articles and holds half a dozen patents. Dileep’s interests and expertise include new and disruptive technologies, their market potential and commercialization aspects, in particular, Energy storage, Water, Solar, Nuclear, Semiconductors, X-rays, and new Materials for various industries.

Lyle Deitch - Principal

Lyle Deitch sits on the Board of portfolio company Advanced Telemetry.

Lyle has a strong background in venture capital and early stage technology company development having spent several years as a Principal of Internet Partnership Group, a technology incubator and investment fund in New York. Lyle is also an accomplished entrepreneur having founded and successfully exited American Mold Testing, a high growth environmental remediation firm in Manhattan, and Dimension Online Media, a technology consulting firm also in Manhattan. Prior to joining 21 Ventures, Lyle served as Director of Business Development for PropertyRoom.com, an online auction site serving the municipal and law enforcement communities.

Lyle holds an MBA from the University of Oxford and a BS in Commerce with a Concentration in Accounting from the University of Virginia. At Oxford, Lyle founded the Said Business School Venture Fund, the first student managed venture fund in Europe.

Meghan Sharp - Intern

Dr. Meghan Sharp is an intern at 21 Ventures while completing her MBA at Columbia University. Prior to business school, Meghan interned with Burrill & Company/Malaysian Life Science Venture Capital Fund in San Francisco, CA, where she advised on palm (biofuel), algal (biofuel), and carbon capture investment opportunities.

Meghan, as a doctoral and post-doctoral researcher, conducted research identifying potential new antibiotic targets, chromosomal changes during ageing, and the role of plant stem cell populations in development. She authored and co-authored numerous publications in leading scientific journals such as Cell, Genes & Development, and Molecular Cell, and presented at International Conferences organized by groups such as the Genetics Society of America and at the Cold Spring Harbor Laboratory meetings. Meghan was a recipient of numerous grants and fellowships from institutions including the National Science Foundation and American Cancer Society.

Meghan received her PhD in Bacterial Genetics from the University of California, San Francisco and performed post-doctoral work at the University of Chicago and the Carnegie Institution of Washington at Stanford University.

Ling Bai Burke - Intern

Ling is an intern at 21 Ventures. She has extensive entrepreneurial experience and has been involved in 3 start-up companies - Dragon Tea, Software Sourcing Inc., and Solar Engineering Solutions, which has received over $2 million in funding from angel investors. Ling previously worked at Schlumberger, a world leading oilfield services company, in the oilfield operation group. Ling also worked at Dioptics Medical Products and managed global sunglasses supply chain for its biggest customer, Wal-Mart. Dioptics Medical Products was a private equity portfolio company and was acquired by FGX International in 2008.

Ling holds Masters of Engineering degree from MIT. She also has a strong financial background, having taken all CPA classes at California Polytechnic State University and received a Bachelor’s degree in Economics from Jilin University in China.

Tal Avrahami - Intern

Tal is an intern at 21Ventures. He brings valuable experience in finance and management consulting, having worked at Orion Consultants advising senior sales and trading managers at the world’s leading investment banks. Tal has also been involved with Great Circle Capital, a private equity investment firm specializing in buyout and expansion capital opportunities within the global transportation network.

Tal received his B.A. in Political Science from Amherst College and is currently pursuing a M.S. in Sustainable Systems at the University of Michigan.

Aamir Sadiq - Intern

Aamir Sadiq graduated with a First Class Honors degree in Chemical and Materials Engineering from the Royal Military College (RMC). He served as an Officer in the Corps of Engineers for 8 years, and completed a Department of Defense and DARPA sponsored Master’s Thesis for which he designed, fabricated, and commissioned an Air Independent Direct Methanol Fuel Cell System for Naval Submarines and Propulsion systems. Part of his work is published in the Journal of Power Sources.

After leaving the Department of Defense, he was a Principal Scientist at DuPont’s Advanced Research and Business Development Center in the Electropolymers Research Division where he developed Alternative Energy Devices and worked on specialized fuel cell polymer membranes. He later served on the Executive Staff of an Alternative Energy Development Company based in New York, where he led a team to achieve a Guinness World Record for a Fuel Cell Vehicle.

Aamir went on to attend Cornell University in New York where he received his MBA in Finance – Investment Banking. He also attended the Stockholm School of Economics in Sweden specializing in option pricing and international accounting. Thereafter, Aamir was an Investment Banker in Risk Management and Mergers and Acquisitions at Lehman Brothers and Nomura Securities. Aamir has experience in firm valuation analysis, asset pricing models, and other structured debt analysis. He has also broad experience in corporate management and restructuring, from a financial and an operational standpoint.

Aamir is presently pursuing a degree in Financial Engineering from the University of Chicago, and is in the final step of securing his CFA charter. Aamir currently serves as the Executive Chair of Finance for the MENSA Society of New York, and sits on the boards of several other organizations, and is involved in several charitable organizations in North America. He also holds a Professional Engineer designation and a Project Management Professional designation.

Jinming Zhang - Intern

Jinming Zhang, provides consulting services for 21Ventures in potential investment opportunity evaluation, due diligence and various technology fields, including Clean Technology, Biotechnology/Pharmaceuticals and Information Technology. Jinming is currently working as a project manager and senior business analyst at Bristol-Myers Squibb Company, one of the largest pharmaceutical companies in the world. Prior to BMS, Jinming worked as a business analyst for Wyeth Pharmaceuticals, a worldwide pharmaceutical company acquired by Pfizer.

Jinming was educated in multiple disciplines. He received a BS in Biopharmaceuticals, a MS in Biochemical Engineering and a Ph.D. in Biochemistry. Jinming had good experience in entrepreneurship. He participated several business plan competitions. Jinming is the co-founder of a business management and technology consulting firm providing services for small and medium sized companies.